Literature DB >> 20889602

Clinical relevance of nitric oxide metabolites and nitrative stress in thrombotic primary antiphospholipid syndrome.

Paul R J Ames1, Joana R Batuca, Antonio Ciampa, Luigi Iannaccone, Jose Delgado Alves.   

Abstract

OBJECTIVE: To assess the role of nitrite (NO(2)(-)), nitrate (NO(3)(-)), and nitrative stress in thrombotic primary antiphospholipid syndrome (PAPS).
METHODS: We investigated 46 patients with PAPS: 21 asymptomatic but persistent carriers of antiphospholipid antibodies (PCaPL), 38 patients with inherited thrombophilia (IT), 33 patients with systemic lupus erythematosus (SLE), and 29 healthy controls (CTR). IgG anticardiolipin (aCL), IgG anti-beta(2)-glycoprotein I (anti-ß(2)-GPI), IgG anti-high density lipoprotein (aHDL), IgG anti-apolipoprotein A-I (aApoA-I), crude nitrotyrosine (NT) (an indicator of nitrative stress), and high sensitivity C-reactive protein (CRP) were measured by immunoassays. Plasma nitrite (NO(2)(-)), nitrate (NO(3)(-)), and total antioxidant capacity (TAC) were measured by colorimetric spectroscopic assays.
RESULTS: Average plasma NO(2)(-) was lower in PAPS, PCaPL, and IT (p < 0.0001); average NO(3)(-) was highest in SLE (p < 0.0001), whereas average NT was higher in PAPS and SLE (p = 0.01). In thrombotic PAPS, IgG aCL titer and number of vascular occlusions negatively predicted NO(2)(-) (p = 0.03 and p = 0.001, respectively), whereas arterial occlusions and smoking positively predicted NO(3)(-) (p = 0.05 and p = 0.005), and CRP positively predicted NT (p = 0.004). In the PCaPL group IgG aCL negatively predicted NO(3)(-) (p = 0.03). In the SLE group IgG aCL negatively predicted NO(2)(-) (p = 0.03) and NO(3)(-) (p = 0.02).
CONCLUSION: PAPS is characterized by decreased NO(2)(-) in relation to type and number of vascular occlusions and to aPL titers. Nitrative stress and low grade inflammation are linked phenomena in PAPS and may have implications for thrombosis and atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20889602     DOI: 10.3899/jrheum.100494

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  11 in total

1.  New Insights into the Molecular Basis of the Antiphospholipid Syndrome.

Authors:  Chieko Mineo; Philip W Shaul
Journal:  Drug Discov Today Dis Mech       Date:  2011

Review 2.  Why are kids with lupus at an increased risk of cardiovascular disease?

Authors:  Catherine Quinlan; Stephen D Marks; Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2015-09-23       Impact factor: 3.714

3.  Lipid peroxidation as risk factor for endothelial dysfunction in antiphospholipid syndrome patients.

Authors:  Natasa Stanisavljevic; L Stojanovich; D Marisavljevic; A Djokovic; V Dopsaj; J Kotur-Stevuljevic; J Martinovic; L Memon; S Radovanovic; B Todic; D Lisulov
Journal:  Clin Rheumatol       Date:  2016-08-25       Impact factor: 2.980

Review 4.  Inhibition of nitric oxide and antiphospholipid antibody-mediated thrombosis.

Authors:  Chieko Mineo
Journal:  Curr Rheumatol Rep       Date:  2013-05       Impact factor: 4.592

Review 5.  New Insights in the Pathophysiology of Antiphospholipid Syndrome.

Authors:  Anastasia Sacharidou; Philip W Shaul; Chieko Mineo
Journal:  Semin Thromb Hemost       Date:  2017-01-27       Impact factor: 6.398

Review 6.  Antiphospholipid Syndrome and the Neurologist: From Pathogenesis to Therapy.

Authors:  Thomas Fleetwood; Roberto Cantello; Cristoforo Comi
Journal:  Front Neurol       Date:  2018-11-26       Impact factor: 4.003

7.  Hydroxychloroquine partially prevents endothelial dysfunction induced by anti-beta-2-GPI antibodies in an in vivo mouse model of antiphospholipid syndrome.

Authors:  Geoffrey Urbanski; Antoine Caillon; Caroline Poli; Gilles Kauffenstein; Marc-Antoine Begorre; Laurent Loufrani; Daniel Henrion; Cristina Belizna
Journal:  PLoS One       Date:  2018-11-06       Impact factor: 3.240

Review 8.  Managing Antiphospholipid Syndrome in Children and Adolescents: Current and Future Prospects.

Authors:  Aline Garcia Islabão; Vitor Cavalcanti Trindade; Licia Maria Henrique da Mota; Danieli Castro Oliveira Andrade; Clovis Artur Silva
Journal:  Paediatr Drugs       Date:  2021-12-13       Impact factor: 3.022

Review 9.  Renal Involvement in Antiphospholipid Syndrome.

Authors:  Alonso Turrent-Carriles; Juan Pablo Herrera-Félix; Mary-Carmen Amigo
Journal:  Front Immunol       Date:  2018-05-17       Impact factor: 7.561

Review 10.  Coagulation Disorders and Thrombosis in COVID-19 Patients and a Possible Mechanism Involving Endothelial Cells: A Review.

Authors:  An-Tian Chen; Chen-Yu Wang; Wen-Ling Zhu; Wei Chen
Journal:  Aging Dis       Date:  2022-02-01       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.